AXQ Capital’s Veracyte VCYT Stock Holding History

AXQ Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9,080	Closed	-$245K	–	841
2025 Q2	$245K	Buy	+9,080	New	+$263K	0.08%	419
2023 Q1	–	Sell	-10,383	Closed	-$246K	–	652
2022 Q4	$246K	Buy	+10,383	New	+$241K	0.17%	217

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AXQ Capital's VCYT Position: Q3 2025 in Review

AXQ Capital sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 9,080 shares — an estimated $245K sold.

AXQ Capital first reported a position in VCYT in Q4 2022 and held it in 2 quarters. The position peaked at $246K in Q4 2022. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

AXQ Capital reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
AXQ Capital sold 9,080 Veracyte shares in Q3 2025, an estimated $245K.
AXQ Capital first reported a position in Veracyte in Q4 2022 and held it in 2 quarters.
AXQ Capital's Veracyte position peaked at $246K in Q4 2022.
298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on AXQ Capital's 13F filing for Q3 2025, filed 10 Nov 2025.